Ondansetron Tablet, Orally Disintegrating
Product Images NDC 68071-3268

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 68071-3268). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure-hcl (Structure HCl)

Chemical structure of Ondansetron hydrochloride dihydrate, showing its molecular configuration with the hydrochloride (HCl) and two water molecules (2H2O) components.*

FDA Label Image

Structure-base (Structure Base)

Chemical structure of Ondansetron, showing the molecular arrangement and bonding of its chemical components.*

FDA Label Image

Pdp (68071 3268 6 (2))

Packaging label for Ondansetron 4 mg orally disintegrating tablets by NuCare Pharmaceuticals, Inc. The label shows a bottle pack of 6 tablets with NDC 68071-3268-6. It includes information on active ingredients including phenylalanine content, directions to take one tablet every 8 hours, and storage instructions at controlled room temperature. The label also contains lot and expiration date fields, a barcode, and safety warnings.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.